Infinity Pharmaceuticals CEO on New Cancer Drug

In this interview with NBR, Infinity Pharmaceuticals CEO Adelene Perkins addresses the major drop in the company’s shares on Monday, and Infinity’s latest cancer drug.

This entry was posted in CEO Interviews. Bookmark the permalink.

Leave a Reply